Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bernard Communications was a specialized medical communications agency that provided strategic and scientific communication services to the global pharmaceutical and biotechnology sectors. The firm focused on medical education, publication planning, and advisory board management, helping life science companies translate complex clinical data into impactful narratives for healthcare professionals. In 2008, the company was acquired by UDG Healthcare (now Inizio) for an initial consideration of £6.5 million. Following the acquisition, it was integrated into the Ashfield Medical Communications division, enhancing the group's capabilities in scientific engagement and medical affairs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bernard Communications.